HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Ozawa Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

12/2014Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis.
8/2014HLA-C*12:02 is a susceptibility factor in late-onset type of psoriasis in Japanese.
6/2014Case of generalized pustular psoriasis with end-stage renal disease successfully treated with granulocyte monocyte apheresis in combination with hemodialysis.
11/2013IL12B and IL23R gene SNPs in Japanese psoriasis.
9/2013Japanese guidance for use of biologics for psoriasis (the 2013 version).
4/2013Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
12/2012Development of psoriasis 10 years after allogeneic hematopoietic cell transplantation from non-psoriatic donor: Further evidences for genetics and immunopathogenesis of psoriasis.
3/2012Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
3/2012Current understanding of human genetics and genetic analysis of psoriasis.
5/2011Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Ozawa Research Topics

Disease

17Psoriasis (Pustulosis Palmaris et Plantaris)
12/2014 - 10/2002
10Neoplasms (Cancer)
04/2017 - 02/2003
4Carcinoma (Carcinomatosis)
05/2014 - 09/2006
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 11/2010
3Neoplasm Metastasis (Metastasis)
04/2010 - 09/2005
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2011 - 04/2010
2Skin Diseases (Skin Disease)
07/2005 - 07/2005
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Retroperitoneal Fibrosis
11/2017
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2017
1Fibrosis (Cirrhosis)
01/2016
1Keloid
01/2016
1Eczema
09/2014
1Granuloma
09/2014
1Foreign-Body Granuloma (Granuloma, Foreign Body)
09/2014
1Wounds and Injuries (Trauma)
06/2014
1Skin Ulcer
06/2014
1Chronic Kidney Failure (Chronic Renal Failure)
06/2014
1Papilloma (Papillomatosis)
03/2014
1Diabetes Mellitus
03/2014
1Acanthosis Nigricans
03/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2013
1Drug-Related Side Effects and Adverse Reactions
09/2013
1Infections
09/2013
1Tuberculosis (Tuberculoses)
09/2013
1Hepatitis B
09/2013
1Alopecia Areata
07/2013
1Autoimmune Diseases (Autoimmune Disease)
07/2013
1Chromoblastomycosis (Chromomycosis)
04/2012
1Hyperostosis
03/2012
1Growth Disorders
03/2012
1Bowen's Disease (Disease, Bowen)
07/2011
1Nocardia Infections
07/2011
1Carcinogenesis
06/2011
1Sunburn
12/2010
1Body Weight (Weight, Body)
04/2010
1Aortic Coarctation
06/2009

Drug/Important Bio-Agent (IBA)

5Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2013 - 02/2003
4GemcitabineFDA Link
08/2010 - 09/2006
4Cisplatin (Platino)FDA LinkGeneric
08/2010 - 09/2006
3HLA-C Antigens (HLA-C)IBA
08/2014 - 03/2012
3EtretinateFDA Link
04/2013 - 02/2003
3Messenger RNA (mRNA)IBA
11/2010 - 10/2002
2SteroidsIBA
11/2017 - 09/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2014 - 09/2013
2HLA-C*06 antigenIBA
08/2014 - 05/2011
2Keratins (Keratin)IBA
05/2014 - 03/2014
2Interleukin-23 (Interleukin 23)IBA
11/2013 - 03/2012
2Interleukin-12 (IL 12)IBA
11/2013 - 09/2013
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2013 - 03/2007
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2013 - 02/2003
2Histone Deacetylase InhibitorsIBA
06/2011 - 04/2010
2DNA (Deoxyribonucleic Acid)IBA
06/2011 - 12/2010
2Methotrexate (Mexate)FDA LinkGeneric
09/2006 - 02/2003
1Anaplastic Lymphoma KinaseIBA
04/2017
1Anti-Bacterial Agents (Antibiotics)IBA
04/2017
1CollagenIBA
01/2016
1Leuprolide (Lupron)FDA LinkGeneric
09/2014
1Acetates (Acetic Acid Esters)FDA Link
09/2014
1HSc025IBA
06/2014
1CAM 5.2 antigenIBA
05/2014
1Melanins (Melanin)IBA
05/2014
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
03/2014
1Insulin (Novolin)FDA Link
03/2014
1CytokinesIBA
11/2013
1Interleukin-12 Subunit p40IBA
11/2013
1Infliximab (Remicade)FDA Link
09/2013
1Ustekinumab (CNTO 1275)FDA Link
09/2013
1Therapeutic UsesIBA
09/2013
1Monoclonal AntibodiesIBA
09/2013
1Adalimumab (Humira)FDA Link
09/2013
1Cholecalciferol (Vitamin D3)FDA Link
04/2013
1Terbinafine (Lamisil)FDA LinkGeneric
04/2012
1calcipotriene (calcipotriol)FDA LinkGeneric
03/2012
1RetinoidsIBA
03/2012
1ArsenicIBA
07/2011
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2011
1CarcinogensIBA
06/2011
1Histones (Histone)IBA
06/2011
1Proteins (Proteins, Gene)FDA Link
06/2011
1A-factor (Streptomyces)IBA
11/2010
1EnzymesIBA
11/2010
1Nucleic AcidsIBA
11/2010
1Valproic Acid (Depakote)FDA LinkGeneric
04/2010
1Histone Deacetylases (Histone Deacetylase)IBA
04/2010
1NitrosaminesIBA
04/2010
1Coenzyme A (CoA)IBA
06/2009
1dimemorfan (AT 17)IBA
11/2008

Therapy/Procedure

14Therapeutics
11/2017 - 04/2003
2Injections
03/2014 - 09/2005
2Drug Therapy (Chemotherapy)
08/2010 - 08/2007
1Pelvic Exenteration
01/2019
1Occlusive Dressings (Occlusive Dressing)
09/2014
1Subcutaneous Injections
09/2014
1Renal Dialysis (Hemodialysis)
06/2014
1Blood Component Removal (Apheresis)
06/2014
1Phototherapy (Light Therapy)
04/2013
1Cell Transplantation
12/2012
1Oral Administration
04/2012
1Prostatectomy (Retropubic Prostatectomy)
11/2010